The DISCOVER Trial (Diagnosis of Infection in Stem Cell Transplant Patients OVER Time)
Active, not recruiting
- Conditions
- Bone Marrow Transplant Infection
- Registration Number
- NCT02804464
- Lead Sponsor
- Karius, Inc.
- Brief Summary
Demonstrate that the Karius Infectious Disease Diagnostic Sequencing Assay performed on plasma can accurately detect the microbiologic etiology in febrile allogeneic stem-cell transplant patients when compared with standard clinical diagnostics
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
- 18 years of age or older
- Patients who plan on undergoing an allogeneic stem cell transplant and are admitted to UCSF Medical Center.
Exclusion Criteria
- Inability to provide informed consent and comply with study-related procedures
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Demonstrate that the Karius Infectious Disease Diagnostic Sequencing Assay performed on plasma can accurately detect the microbiologic etiology in febrile allogeneic stem-cell transplant patients when compared with standard clinical diagnostics. 7 days
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University of California, San Francisco
🇺🇸San Francisco, California, United States